XTLB Latest Press Releases

-- April 29, 2026 --

XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologies Globe Newswire 8:58 AM

-- March 20, 2026 --

XTL Biopharmaceuticals Announces ADS Ratio Change Globe Newswire 4:10 PM

-- February 27, 2026 --

XTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request Hearing Globe Newswire 4:30 PM

-- January 29, 2026 --

XTL Update on Recent Developments Globe Newswire 4:05 PM

-- January 23, 2026 --

XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders' Equity Deficiency Globe Newswire 4:10 PM

-- January 13, 2026 --

XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership Globe Newswire 9:28 AM

XTL Biopharmaceuticals Acquires 85% of Beyond Air's Subsidiary NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership Globe Newswire 7:30 AM

-- December 24, 2025 --

XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency Globe Newswire 4:00 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software